Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015 (2015), Article ID 680853, 6 pages
http://dx.doi.org/10.1155/2015/680853
Review Article

Increased Risk of Cancer in relation to Gout: A Review of Three Prospective Cohort Studies with 50,358 Subjects

1Department of Neurosurgery, Huai’an First People’s Hospital Affiliated to Nanjing Medical University, 6 Beijing Road West, Huai’an 223300, China
2Department of Rheumatology, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
3Liver Transplantation Center of the First Affiliated Hospital and State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 210002, China
4Department of Endocrinology, The Affiliated Hospital of Medical College, Qingdao University, Qingdao 266003, China
5Department of Surgical Oncology, The Eighty-First Hospital of People’s Liberation Army, Nanjing 210002, China

Received 15 July 2014; Revised 1 September 2014; Accepted 10 September 2014

Academic Editor: Sydney C. W. Tang

Copyright © 2015 Weijie Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. C. Robinson and S. Horsburgh, “Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities,” Maturitas, vol. 78, no. 4, pp. 245–251, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Richette and T. Bardin, “Gout,” The Lancet, vol. 375, no. 9711, pp. 318–328, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Doherty, “New insights into the epidemiology of gout,” Rheumatology, vol. 48, supplement 2, pp. ii2–ii8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Cai, Y. H. Peng, Z. Tang et al., “Association of Toll-like receptor 2 polymorphisms with gout,” Biomedical Reports, vol. 2, no. 2, pp. 292–296, 2014. View at Google Scholar
  5. D. Grassi, L. Ferri, G. Desideri et al., “Chronic hyperuricemia, uric acid deposit and cardiovascular risk,” Current Pharmaceutical Design, vol. 19, no. 13, pp. 2432–2438, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. C.-F. Kuo, S.-F. Luo, L.-C. See, I.-J. Chou, Y.-F. Fang, and K.-H. Yu, “Increased risk of cancer among gout patients: a nationwide population study,” Joint Bone Spine, vol. 79, no. 4, pp. 375–378, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Strasak, K. Rapp, W. Hilbe et al., “Serum uric acid and risk of cancer mortality in a large prospective male cohort,” Cancer Causes and Control, vol. 18, no. 9, pp. 1021–1029, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. Strasak, K. Rapp, W. Hilbe et al., “The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women,” Annals of Oncology, vol. 18, no. 11, pp. 1893–1897, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. Fini, A. Elias, R. J. Johnson, and R. M. Wright, “Contribution of uric acid to cancer risk, recurrence, and mortality,” Clinical and Translation Medicine, vol. 1, no. 1, p. 16, 2012. View at Publisher · View at Google Scholar
  10. L. Baeksgaard and J. B. Sørensen, “Acute tumor lysis syndrome in solid tumors: a case report and review of the literature,” Cancer Chemotherapy and Pharmacology, vol. 51, no. 3, pp. 187–192, 2003. View at Google Scholar · View at Scopus
  11. S. G. Wannamethee, “Serum uric acid and risk of coronary heart disease,” Current Pharmaceutical Design, vol. 11, no. 32, pp. 4125–4132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. B. N. Ames, R. Cathcart, E. Schwiers, and P. Hochstein, “Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 11, pp. 6858–6862, 1981. View at Publisher · View at Google Scholar · View at Scopus
  13. C. J. Chen, J. H. Yen, and S. J. Chang, “Gout patients have an increased risk of developing most cancers, especially urological cancers,” Scandinavian Journal of Rheumatology, 2014. View at Publisher · View at Google Scholar
  14. W. G. Cochran, “The comparison of percentages in matched samples,” Biometrika, vol. 37, no. 3-4, pp. 256–266, 1950. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  15. J. P. T. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, “Measuring inconsistency in meta-analyses,” British Medical Journal, vol. 327, no. 7414, pp. 557–560, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Mantel and W. Haenszel, “Statistical aspects of the analysis of data from retrospective studies of disease,” Journal of the National Cancer Institute, vol. 22, no. 4, pp. 719–748, 1959. View at Google Scholar
  17. R. DerSimonian and N. Laird, “Meta-analysis in clinical trials,” Controlled Clinical Trials, vol. 7, no. 3, pp. 177–188, 1986. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Egger, G. D. Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” The British Medical Journal, vol. 315, no. 7109, pp. 629–634, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. A. E. Stuck, L. Z. Rubenstein, and D. Wieland, “Bias in meta-analysis detected by a simple, graphical test: asymmetry detected in funnel plot was probably due to true heterogeneity,” British Medical Journal, vol. 316, no. 7129, pp. 469–471, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Boffetta, C. Nordenvall, O. Nyren, and W. Ye, “A prospective study of gout and cancer,” European Journal of Cancer Prevention, vol. 18, no. 2, pp. 127–132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K.-H. Yu, C.-F. Kuo, S.-F. Luo et al., “Risk of end-stage renal disease associated with gout: a nationwide population study,” Arthritis Research and Therapy, vol. 14, no. 2, article R83, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. C.-F. Kuo, K.-H. Yu, L.-C. See et al., “Risk of myocardial infarction among patients with gout: a nationwide population-based study,” Rheumatology, vol. 52, no. 1, pp. 111–117, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. M. Fraile, R. J. Torres, M. E. de Miguel et al., “Metabolic syndrome characteristics in gout patients,” Nucleosides, Nucleotides and Nucleic Acids, vol. 29, no. 4–6, pp. 325–329, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. G. Puig and M. A. Martínez, “Hyperuricemia, gout and the metabolic syndrome,” Current Opinion in Rheumatology, vol. 20, no. 2, pp. 187–191, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. V. C. Kok, J.-T. Horng, H.-L. Lin, Y.-C. Chen, Y.-J. Chen, and K. F. Cheng, “Gout and subsequent increased risk of cardiovascular mortality in non-diabetics aged 50 and above: a population-based cohort study in Taiwan,” BMC Cardiovascular Disorders, vol. 12, article 108, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. D. B. Peden, R. Hohman, M. E. Brown et al., “Uric acid is a major antioxidant in human nasal airway secretions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 19, pp. 7638–7642, 1990. View at Publisher · View at Google Scholar · View at Scopus
  27. A. E. Mirrakhimov, A. M. Ali, M. Khan, and A. Barbaryan, “Tumor lysis syndrome in solid tumors: an up to date review of the literature,” Rare Tumors, vol. 6, article 5389, no. 2, 2014. View at Publisher · View at Google Scholar
  28. S. Jeha, “Tumor lysis syndrome,” Seminars in Hematology, vol. 38, no. 4, supplement 10, pp. 4–8, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Mazza, E. Casiglia, R. Scarpa et al., “Predictors of cancer mortality in elderly subjects,” European Journal of Epidemiology, vol. 15, no. 5, pp. 421–427, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Tomita, S. Mizuno, H. Yamanaka et al., “Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers,” Journal of Epidemiology, vol. 10, no. 6, pp. 403–409, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. L. N. Kolonel, C. Yoshizawa, A. M. Nomura, and G. N. Stemmermann, “Relationship of serum uric acid to cancer occurrence in a prospective male cohort,” Cancer Epidemiology Biomarkers and Prevention, vol. 3, no. 3, pp. 225–228, 1994. View at Google Scholar · View at Scopus
  32. S. H. Jee, S. Y. Lee, and M. T. Kim, “Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men,” European Journal of Cardiovascular Prevention and Rehabilitation, vol. 11, no. 3, pp. 185–191, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus